Clinical Trial Update: Study Comparing a DTaP-HB-PRP~T Combined Vaccine With Tritanrix HepB/Hib™, Concomitantly With OPV in Healthy Infants [Phase 3]

View source ↗

Summary

Phase 3 trial comparing DTaP-HB-PRP~T with Tritanrix HepB/Hib, administered concomitantly with OPV in healthy infants; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type Infection
• Hepatitis B
• Pertussis
• Tetanus

Drugs mentioned

• DTaP-HB-PRP-T (Diphtheria, Tetanus, acellular Pertussis, Hepatitis B, Haemophilus influenzae type b conjugate vaccine)
• Tritanrix-HepB/Hib

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Diphtheria, Tetanus | Phase 3 | Status: COMPLETED | Results posted: 2013-10-22